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Abstract
Background: Second messengers, such as calcium, regulate the activity of multisite binding proteins in a
concentration-dependent manner. For example, calcium binding has been shown to induce conformational
transitions in the calcium-dependent protein calmodulin, under steady state conditions. However, intracellular
concentrations of these second messengers are often subject to rapid change. The mechanisms underlying
dynamic ligand-dependent regulation of multisite proteins require further elucidation.
Results: In this study, a computational analysis of multisite protein kinetics in response to rapid changes in ligand
concentrations is presented. Two major physiological scenarios are investigated: i) Ligand concentration is abundant
and the ligand-multisite protein binding does not affect free ligand concentration, ii) Ligand concentration is of the
same order of magnitude as the interacting multisite protein concentration and does not change. Therefore, buffering
effects significantly influence the amounts of free ligands. For each of these scenarios the influence of the number of
binding sites, the temporal effects on intermediate apo- and fully saturated conformations and the multisite regulatory
effects on target proteins are investigated.
Conclusions: The developed models allow for a novel and accurate interpretation of concentration and pressure
jump-dependent kinetic experiments. The presented model makes predictions for the temporal distribution of multisite
protein conformations in complex with variable numbers of ligands. Furthermore, it derives the characteristic time and
the dynamics for the kinetic responses elicited by a ligand concentration change as a function of ligand concentration
and the number of ligand binding sites. Effector proteins regulated by multisite ligand binding are shown to depend
on ligand concentration in a highly nonlinear fashion.
Keywords: Ligand-receptor binding, Transient kinetics, Calcium, Calmodulin
Background
A wide variety of intracellular events are initiated via
temporal change of ligand concentrations. One of the
most important ligands in many cells is calcium (Ca2+).
Calcium interacts with and regulates the activities of a
large number of calcium-binding proteins as well as
numerous effectors. The number of functional calcium
binding sites within these proteins can range from one
or two to ten or more [1–3]. The most common number
of calcium binding sites is four: as observed in the most
ubiquitous protein, calmodulin as well as troponin
and other EF-hand containing proteins [4, 5]. Tem-
poral elevation of intracellular free Ca2+ is the key
regulatory factor of the Ca2+-dependent protein activ-
ity [6–10]. The characteristics of the induced signal
are not fully understood. It remains to be determined
how a single ligand is able to govern numerous intra-
cellular properties.
Whilst the multisite ligand binding is not limited to
Ca2+ signaling, Ca2+ is probably the most versatile ion,
regulating the largest number of cellular events. Several
Ca2+-binding proteins can be considered as examples of
multisite ligand protein interactions. Structural biology
investigations of calcium binding proteins in complexes
with target protein peptides have suggested that the
specificity in Ca2+-CaM binding protein-dependent
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target activation arises from the diversity of interaction
interfaces between the Ca2+-regulated protein and its
target proteins [5, 11–21]. The most ubiquitous protein,
calmodulin (CaM), consists of two globular domains,
each domain containing a pair of helix-loop-helix Ca2
+-binding motifs called EF-hands [1, 3, 5, 16, 17]. In earl-
ier studies the authors demonstrated that in addition to
the diversity of CaM-target interfaces; the CaM selectiv-
ity emerges from its target specific Ca2+-affinity; the
number of Ca2+ ions bound and the target specific coop-
erativity [22–24].
Another major factor that contributes to the selectiv-
ity of seemingly simultaneous regulation of several
multisite Ca2+ binding proteins and Ca2+-mediated
processes is the temporal alterations of Ca2+ [25–27].
The remarkable variety of Ca2+ signals in cells, ranging
from infrequent spikes to sustained oscillations and
plateaus, requires an understanding of how fast intracellu-
lar calcium changes regulate the kinetics of multiple
multisite Ca2+ binding proteins. Therefore mathematical
modeling of Ca2+ jump induced responses could prove to
be invaluable in the interpretation of transient kinetic
experiments.
Cooperative binding is a special case of molecular in-
teractions where ligand binding to one site of a mol-
ecule depends on the ligand binding to the other sites.
The first quantitative determination of the dynamic
properties of cooperative binding was proposed by [28].
In this work the authors emphasized the significance of
the cooperativity by studying the fast dynamics of Ca2+
binding to calretenin (CR), which has one independent
and four cooperative binding sites. The investigation of
cooperative effects of Ca2+ binding to CR was per-
formed both experimentally and using mathematical
modeling. The authors employed the simplified version
of the Adair-Klotz model [29, 30] to describe the dy-
namics of the interactions involved in Ca2+ binding to
CR. This approach was then extended to the binding of
Ca2+ to CaM [31]. The models proposed in these stud-
ies [28, 31] demonstrated excellent fitting results to the
experimental data, in comparison with the previously
published models. However, the described approach is
rather limited, as it describes fitting instead of provid-
ing a mechanistic description. An alternative method-
ology offered by [28, 31] is not directly applicable from
the physical and chemical point of view because the
Adair-Klotz model for sequential ligand binding was
utilized [29, 30] whereas binding of Ca2+ to EF-hand
proteins [32–35] is non-sequential [22]. Given the im-
portance of studying fast Ca2+ binding kinetics and the
lack of understanding of the underlying mechanisms,
we developed a detailed mathematical model for ligand
binding to multisite proteins with both cooperative and
independent binding sites.
Mathematical modelling of multisite protein kinetics in
response to rapid ligand changes presented in this paper
provide new insights into the mechanism of conform-
ational kinetics of multisite proteins in complex with
variable number of bound ligands for the two distinct
physiological situations described:
i) When the ligand concentration significantly exceeds
protein concentration,
ii) When the total amount of ligand is conserved and
comparable with the protein concentration.
In the first case, the buffering effects are negligible
whereas in the latter, the ligand-protein interactions
have a significant impact on the amount of available
ligand and the binding kinetics. In this work, the equa-
tions for the dependence of the characteristic time
constants and the temporal distribution of individual
conformations as a function of the ligand concentra-
tion, the number of binding sites and the binding
affinities have been derived. The impact of the number
of binding sites, temporal effects on conformations,
and regulation by multisite proteins of their effector
proteins have been investigated by employing the devel-
oped models. The analysis of the ligand-multisite pro-
tein mediated regulation of effector proteins suggests
that significant degree of selectivity in regulation can be
achieved by a single ligand by employing mechanisms
described in this study.
Results
A new model for multisite protein ligand binding kinetics
The majority of studies of the activation of multisite pro-
teins consider only the ligand concentration-dependent
profiles. One of the interesting questions about these
multisite proteins is how temporal alterations of ligand
concentration contribute to their function. The shape of
distribution of multisite proteins in complex with variable
numbers of bound ligand is known or can be experimen-
tally elucidated in many cases [4, 5, 16, 22–24, 36–38].
However, the role of temporal transitions caused by fast
alteration of ligand concentration on multisite proteins
and on multisite protein-regulated target proteins remains
unclear. It is reasonable to assume that there can be at
least two distinct mechanisms of fast ligand alteration-
mediated effects exhibited in two distinct system scenar-
ios: i) the ligand concentration is significantly greater than
the multisite protein concentration, ii) the ligand is com-
parable with the multisite protein concentration. In the
first scenario ligand binding to multisite protein leads to
insignificant changes of free ligand, whereas in the second
case, free ligand concentration can vary substantially when
ligand molecules bind to the multisite proteins. This paper
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describes the development of the two models, which ad-
dress these distinct physiological situations.
The model for abundant ligand concentration
In this model we describe physiological situations where
the ligand concentration significantly exceeds the multi-
site protein concentration. In a previous study [22, 24]
the authors analyzed functions for the probability of an
individual site being in the bound or non-bound state
and a function giving the probability of a multisite pro-
tein being in a complex with different number of bound
ligands (Eqs. (2) and (3) in Methods) [29, 39, 40]. To
investigate the kinetics of the multisite protein ligand
interactions the present study extends the previous
model to consider the ligand concentration as a func-
tion of time (Eqs. (4) and (5) in Methods). The solu-
tions for the individual sites to be in a particular state
were obtained for those cases where ligands are subject
to rapid changes between steady-states (Eqs. (6) and (7)
in Methods). Due to the large number of sites involved,
knowledge of the state probability distribution for indi-
vidual binding sites allows accurate estimation of the
dynamics of the total concentration of bound ligand in
response to a jump in free ligand concentration (Eq.
(11) in Methods).
In order to gain more insights into the distribution
of the intermediate protein conformations (complexes
with variable number of bound ions) we investigated
the case of a multisite protein with identical binding
sites (Eq. (12) in Methods). While this case is a rela-
tively rare occurrence in living cells, it enables insight
into the role that the number of binding sites plays in
cellular signalling. There are several examples of pro-
tein families that have variable number of ligand bind-
ing sites either due to their structural properties or by
them forming large tertiary complexes. For example
members of the Ca2+ family of binding proteins can
differ in the number of ligand binding sites [41, 42].
The most ubiquitous Ca2+-binding protein, calmodulin
(CaM), contains four Ca2+ binding sites as does tropo-
nin (TnC) [18] and calcineurin phosphatase (CaN)
[43]. However the number of functional Ca2+ binding
sites can vary from two to ten as in the protease, cal-
pain [1] or even more in other cases [2]. To investigate
the role that the number of ligand binding sites plays
in multisite kinetics, the ligand concentrations, at which
the intermediate conformations reach their maximum
values, (Eq. (13) in Methods) and the corresponding mag-
nitudes for those conformations (Eq. (14) in Methods)
were estimated.
Figure 1 shows the maximum protein conformations
in complex with one, two and three ligands as a function
of the number of binding sites (Eq. (14) in Methods).
The graph demonstrates that the magnitude of the
ligand-multisite complexes decreases dramatically as the
number of binding sites increases. The presented results
suggest that the relative magnitude of individual inter-
mediate conformations decreases as the number of bind-
ing sites increases. This in turn results in subtler
regulatory effects of those proteins with larger number
of ligand binding sites. For example, in CaM that has
four binding sites for calcium [18], the presence of four
sites leads to the increased multifunctionality of this pro-
tein due to the additional regulatory properties of inter-
mediate conformations [24]. However, as an exception
some forms of CaM have six binding sites [44, 45]. In
this case, according to Fig. 1 the magnitude of inter-
mediate conformations significantly decreases compared
to the case of four binding sites, resulting in decreased
regulatory properties of the protein. The presence of
more than one binding site results in increased multi-
functionality of the protein but at the same time leads
the decrease of the regulatory effects. Thus, it seems that
there is an “optimal” number of binding sites, which
have been developed during the evolution, for instance
four calcium binding sites in CaM.
Next, the ligand concentrations for half maximum ef-
fective ligand concentrations, U0
0.5 and Un
0.5, for the
apo- and saturated multisite protein conformations
when the protein species equals 50 % of the total con-
centration were estimated (Eqs. (15) in Methods). This
solution shows that the ligand concentration for the
half maximal protein activity, known as EC50, would be
equal to the equilibrium dissociation constant K (EC50
= K) for proteins with one binding site only (n = 1).
Figure 2a shows the dependence of U0
0.5/K and Un
0.5/K,
Fig. 1 The effect of the number of binding sites on intermediate
conformations. The maximum magnitude of protein conformations
in complex with one, two and three ligand molecules are shown as
a function of the total number of binding sites. The relative amount
of ligand binding by conformations bound to a specific number of
sites clearly diminishes as the number of sites grow
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on the number of binding sites. The model predicts
that there is a significant change in the required ligand
concentration Un
0.5/K for the fully bound conformation,
while U0
0.5/K does not change with time.
In the previous study the authors reported on the regu-
latory importance of the distribution of individual multi-
site protein conformations [22, 24]. Here calculations
(Eqs. (15) in Methods) are presented for the half-width be-
tween the half-maximal effective ligand concentrations
U0.5/K as a function of the ligand concentration for the
intermediate conformations (one bound ligand) of the
proteins with different number of binding sites (Fig. 2b).
The observation of the half-width for the concentra-
tions of intermediate conformations that have a bell-
shaped dependence on ligand concentration, enables
the range of physiologically plausible concentrations
of ligand, where protein functions can be regulated by
intermediate conformations to be obtained. For ex-
ample, in Fig. 2b the half-width range of calcium con-
centrations is approximately from -1 to 1 on the
logarithmic scale, which corresponds to 10-7M-10-5M
due to the fact that the affinity of calcium binding
sites in CaM is approximately 10-6M [46, 47]. Inter-
estingly, the range 10-7M-10-5M corresponds to the
physiological range of intracellular calcium concentra-
tions in cardiac muscle cells [48]. Within this range
of calcium concentrations, the switching between cal-
cium channel opening and closure takes place [49].
The difference An between ligand concentrations
U0.9/K and U0.1/K for the saturated multisite protein
conformations, when the protein species are equal to
90 % and 10 % of the total concentration, as a function
of the ligand concentration for proteins with different
number of binding sites is shown in Fig. 2c and d re-
spectively. The determination of An allows an under-
standing as to how an increase of the number of
binding sites n affects the steepness of the dose-
response curve (Fig. 2c). It can be seen from Fig. 2c
and d that with an increase of n, the width An decreases
while the steepness increases and shifts to the range of
higher ligand concentrations U/K. The greater steep-
ness of the dose-response curve caused by the presence
of increasing number of binding sites (Fig. 2c) may re-
sult in the switch-like response and ultrasensitivity of
the protein activation [50]. For instance, the steepness
of CaM activation defines the threshold properties for
the switching of erythrocyte aggregation and deform-
ability from one steady-state to another [51].
Equation (17) for the total amount of bound ligand
in the case of multisite protein with identical binding
sites, can be used to estimate the amount of bound lig-
and when the ligand concentration is equal to the
Fig. 2 Model predictions for the half-maximal effective ligand concentrations as a function of the number of binding sites and ligand concentration.
a. The dependence of the half-maximal effective ligand concentration, U0
0.5/K and Un
0.5/K, for the apo- and saturated multisite protein conformations
respectively, on the number of binding sites. The effect of the increasing of the amount of binding sites is negligible for the fully bound conformation.
b. Calculations for the half-width between the half-maximal effective ligand concentrations as a function of the ligand concentration for proteins with
two, three, four and five binding sites. c. The difference between ligand concentrations for the saturated multisite protein conformations when the
protein species equal to 90 % and 10 % of the total concentration as a function of the ligand concentration for the proteins with one to six binding
sites. d. The difference between ligand concentrations for the saturated multisite protein conformations when the protein species equal to 90 % and
10 % of the total concentration as a function of the number of binding sites up to six
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equilibrium dissociation constant (U = K). Our model
predicts that the ligand concentration for the half maximal
protein activation, EC50, is equal to the equilibrium dis-
sociation constant K for any number of bound sites for a
multisite protein with identical binding sites.
Figure 3 shows the calculations for the temporal char-
acteristics of the apo- and fully bound species. Figure 3a
and b show that the temporal shapes of the apo- and
fully bound conformations (Eqs. (19) in Methods) in re-
sponse to a ligand change are similar to the steady-state
dependence of the same conformations on ligand con-
centration [24]. The kinetic parameters, τ0
0.5 and τ4
0.5 can
be estimated as the time required to reach 50 % of the
total concentration (Fig. 3a and b). The described kinetic
parameters have been investigated as a function of the
initial and final ligand concentrations (Fig. 3c, d and
Eqs. (24) in Methods). Our analysis reveals a reduction
of the time constant, τ0
0.5, of the apo- conformation with
the reduction of the initial ligand concentration and an
increase of the final ligand concentration. However, the
dependence of the characteristic time τ4
0.5 (Fig. 3d)
showed an unexpected bell shaped dependence on the
final ligand concentration compared to the simpler
monotonic dependence for τ0
0.5 (Fig. 3c). The model pre-
dicts that there is an “optimal” ligand concentration for
the saturation effect to take the longest time (Fig. 3d).
The bell shaped dependence of τ4
0.5 for a protein with
four binding sites, for example CaM [18], on final ligand
concentration shown in Fig. 3d appears to be related to
the presence of intermediate conformations with one,
two and three bound sites. In a single site molecule
(n = 1), for example crystalline bovine β-trypsin [52]
that is characterized by the absence of intermediate
forms, τ4
0.5 depends on U1/K monotonically, i.e. there
is no bell shaped dependence, as is evident from Eqs.
(24). In CaM (n = 4), the activation of intermediate
conformations takes extra time, which affects τ4
0.5.
This activation precedes the activation of the satu-
rated form in time, and also as U1/K increases, i.e.
the intermediate conformations are more prevalent
for smaller values of U1/K, and the stationary distri-
bution shifts towards the saturated form for larger
U1/K. As a result, an increase of U1/K leads to an
increase of the contribution of the kinetics of the
intermediate complexes to the overall dynamics, and
hence to an increase of τ4
0.5. For larger U1/K the role
of the intermediate conformations is less important
and overall speed-up dominates, hence τ4
0.5 de-
creases. Thus the model predicts that there is an
intermediate ligand concentration, at which the kin-
etics of the fully saturated form, represented by τ4
0.5,
is the slowest.
Fig. 3 Temporal characteristics of the apo- and fully bound species in response to a ligand jump. The dynamics of the concentration of proteins was
investigated for apo- (a) and fully bound (b) forms in response to the non-dimensional ligand concentration change from U0/K = 0.1 to U1/K = 10 as a
function of non-dimensional time η = t ⋅ k−. The dotted lines indicate the time, τ0
0.5, required for the non-dimensional concentration of apo-
conformation, N0/LT, to reach half of the fall in concentration and the period of time, τ40.5, that takes for the fully saturated protein species,
N4/LT, to gain half of the growth in concentration. These kinetic parameters then were subject to the investigation as a function of the
initial (c) and final (d) ligand concentrations. The presented analysis clearly demonstrates the bell shaped dependence of τ40.5 on the final
ligand concentration
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The affinities of binding sites differentially affect the
kinetic responses of intermediate conformations
The proposed model has been employed to investigate
the ligand jump-dependent kinetics of both saturated
and non-saturated conformations. Initially, an idealized
model of a multisite protein with identical binding sites
was used to investigate the impact of ligand concentra-
tions on the multisite protein kinetics. However, in living
cells there are very few proteins (if any) that have identi-
cal ligand binding sites. Therefore the model was ex-
tended to examine the implications of variations in
binding site affinities on the predicted concentration-
response profiles.
Figure 4 shows the dependence of the time point
τm
maxk− when the intermediate protein conformations
reach the maximum as a function of magnitude of ligand
jump (Eqs. (26) in Methods). It can be seen from Eqs.
(26) that τ1
maxk−, τ2
maxk− and τ3
maxk− do not exist for U1=
K < 13 , U1/K < 1 and U1/K < 3, respectively. Under these
special cases, where the ligand concentration U1/K is
not sufficient for the concentrations of the intermediate
conformations to reach their maximal values, these con-
centrations monotonously grow to their respective
steady-state levels. According to Eq. (26), the values U1=
K < 13 ; U1/K < 1 and U1/K < 3 correspond to the three
individual intermediate conformations with one, two
and three bound sites respectively.
To investigate the impact of the dissociation constants
of individual binding sites we employed the multisite
protein model (please see subsection “Multisite proteins
with four different ligand binding sites” in Methods)
with marginally (Fig. 5) and significantly different associ-
ation constants (Fig. 6). The main result that follows
from the analysis of the intermediate conformation
curves is that the affinities of the different binding sites
mainly affect the magnitudes of corresponding protein
conformation. For example, the conformation of a multi-
site protein corresponding to the one ligand bound state
is present in lower concentration if the affinity of the
binding centre is lower. However the overall shape of
the concentration dependent profile has not changed.
This property is very similar to the case of steady-state
dependence on the ligand concentration. The only dif-
ference is that the bell shape dependence on time during
the kinetic response is partially skewed. However, signifi-
cant variation in affinities changes the magnitude, and
also leads to the asynchronous kinetics of the intermedi-
ate conformations.
The effects of cooperativity in Ca2+ binding to CaM
In order to investigate the influence of cooperativity, we
chose a well-characterized protein, CaM, as the model
object. The CaM protein contains two independent EF-
hand globular domains, with two binding sites [1, 3, 5,
16, 17]. The sites within each of the domains coopera-
tively influence each other. It has been reported that co-
operative binding occurs between two neighbouring sites
within the N- and C- terminal domains of CaM [22, 53,
54]. Figure 7 shows the model predictions for CaM
where we assume that the molecule has two independ-
ent domains, with two identical cooperative sites. In the
first domain the affinity of one site changes from K1 =
0.9 μM to K1
c = 0.2 μM if the other site is occupied and
in the second domain the affinity changes from K2 =
0.8 μM to K2
c = 0.1 μM (Eq. (28) in Methods) [22].
Figure 7a and b show the influence of cooperativity on
the steady-state concentrations of CaM with certain
number of bound sites. The presence of cooperativity
shifts the dose-response characteristics along the ligand
concentration axis and changes the magnitude of inter-
mediate conformations allowing more developed select-
ive regulation of the activity of CaM. The investigation
of the dynamic properties of co-operativity in CaM
(Fig. 7c and d) for intermediate, apo- and saturated spe-
cies revealed that the cooperativity influences the magni-
tudes of time-dependent characteristics. The proposed
model predicts that the cooperative binding leads to
more pronounced selective effects for intermediate con-
formations and higher differences between the initial
and steady-state levels for the apo- and saturated forms.
The results of the present analysis suggest that coopera-
tivity plays an important role in the regulation of the activ-
ity of multisite proteins by allowing wider possibilities for
selectivity. However, the presence of cooperativity leads to
Fig. 4 Characteristic time required for intermediate conformations
to reach their maximum levels as a function of the step change
magnitude. The analysis shows that the non-dimensional time
(ηm
max = τm
maxk−, where m = 1, 2 and 3) required for reaching the
maximum level of the intermediate species, is inversely proportional
to the concentration of the applied ligand U1/K. This effect is due to
the growing abundance of the free ligand concentration available
for faster interaction with the multisite protein
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Fig. 5 Kinetics predictions for multisite protein species with marginally different association constants. The kinetics of multisite protein species
was investigated for the intermediate (N1/LT, N2/LT and N3/LT in a as well as the apo- and fully bound conformations (N0/LT and N4/LT respectively
in b in response to step change of ligand from U0/K = 0.001 to U1/K = 1.43 for marginally different association constants h1 = 1, h2 = 0.9, h3 = 0.8,
h4 = 0.7 and the same dissociation constants h1
− = h2
− = h3
− = h4
− = 1. Similar analysis was also performed when step change was U0/K = 0.001, U1/K = 100
for apo- (c) and fully bound (d) forms. The calculations show that the final level of the multisite protein species are defined by the
ligand concentration after the step change. It is very clear that the fully bound species are not saturated and most of the ligand is distributed among
species bound to fewer ligands. However, step change application of ligand with much higher concentration from U0/K = 0.001 to U1/K = 100 for
apo- (c) and fully bound (d) species demonstrate that the application of higher concentrations of ligand causes fully saturates the protein
Fig. 6 Kinetics of multisite protein species alterations for a protein with significantly different association constants. The kinetics of multisite
protein species was investigated in response to step change of ligand from U0/K = 0.001 to U1/K = 8 and to U1/K = 400 for the intermediate (N1/LT,
N2/LT and N3/LT in a, c) as well as apo- and fully bound conformations (N0/LT and N4/LT in b, d), respectively, in the case of significantly different
association h1 = 1, h2 = 0.6, h3 = 0.2, h4 = 0.1 and the same dissociation constants h1
− = h2
− = h3
− = h4
− = 1. The comparison with the kinetics of the
protein with slightly different association constants suggests that in this case the species acquire a degree of asynchronous dynamics
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quantitative rather than qualitative changes in the system.
The introduction of cooperative binding is crucial for the
experimental data fitting but at the same time brings fur-
ther complexity to the system, which does not necessarily
lead to a better understanding of the underlying mecha-
nisms. As a result of this, further analysis was carried out
without considering this effect.
The model for comparable ligand and protein
concentrations
The previous sections considered the physiological case
where the ligand concentration was above saturation level
meaning that the ligand-multisite protein interactions did
not affect the availability of the ligand. Here the case when
the amount of ligand is limited is considered. This can
occur in cases when the ligand concentration level is com-
parable to the multisite protein availability. The model
predictions show the relative redistribution of the ligand
in the free and bound states. The responses of a multisite
protein with four identical binding sites to ligand concen-
tration step change (Eqs. (44) and (45) in Methods)
for two different protein concentrations, LT/K = 2 and
LT/K = 50, were studied (Fig. 8). Instead of considering
absolute ligand concentrations, the approach considered
ratios of the ligand concentration to the affinities of the
binding sites. A borderline case where the free ligand con-
centration is barely affected by interaction was considered
(Fig. 8a and b) as well as a smaller total ligand concentration
where the free ligand is nearly exhausted as a result of buff-
ering by the multisite protein (Fig. 8c and d). The compari-
son of the free ligand concentration (Eqs. (43) and
(44) in Methods) for these two cases is shown in
Fig. 8e. The model predicts that the strongest effect
of the ligand availability can be observed for the mul-
tisite protein conformations with three and four (fully
saturated) bound ligands. A possible explanation for
this phenomenon may be that the multisite protein
conformations, which form complexes with smaller
number of ligand molecules by definition, do not re-
quire significant amount of ligand and as a result are
not strongly affected under conditions when the free
ligand is limited. Whereas the multisite protein inter-
actions with the larger number of ions occur after the
significant amount of ligand is “used up” to form the
intermediate conformations, however is still required
for conformations with larger number of ions. As a
result the final levels of the conformations with three
and four ions are affected. It can also be seen from
Fig. 8 that the shapes of the intermediate conforma-
tions time lines are skewed.
Fig. 7 Comparative analysis of cooperative versus non-cooperative Ca2+ binding to CaM. Two mathematical models for Ca2+-Cam interactions are
compared under the assumptions for the presence and absence of cooperative binding. The comparison between the two scenarios was performed under
steady state conditions (a), (b) and in response to a step change in Ca2+ concentration (c), (d). The model predicts that the cooperativity influences the
maximums of the concentrations for the intermediate forms (N1/LT, N2/LT and N3/LT) as well as the steady-state levels of apo- (N0/LT) and fully saturated
forms (N4/LT). However, the difference observed in the distribution of the conformation species in the presence and absence of the cooperative binding is
quantitative while the overall shape of the distributions remains unchanged. Due to this finding the following model analysis was performed without
cooperative binding assumptions
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Figure 9a shows the model predictions for the charac-
teristic time required for intermediate protein conforma-
tions with one, two and three bound ligands to reach
their highest concentrations in response to a step change
in ligand concentration (Eq. (50) in Methods). The
model predicts that the characteristic time τ0
0.5, required
for the apo- form to reach its half growth level mono-
tonically decreases with the increase of the total ligand
concentration. However, the characteristic time constant
τ4
0.5, which represents the saturated conformation reveals
a distorted bell shaped dependence on ligand concentra-
tion (Fig. 9b and Eqs. (52) in Methods). This bell shaped
dependence, which was also observed in Fig. 3d, can also
be explained by the presence of intermediate confor-
mations. The distortion of the bell shape in Fig. 9b
appears to be due to the ligand consumption that is
included into the consideration in this section and
was not considered in Fig. 3d. This result may be sig-
nificant for the dynamics of CaM activation as our
model predicts that with an increase of the total lig-
and concentration, the limited amount of ligand leads
to an additional increase of τ4
0.5 compared to the case
without the ligand consumption. The model, there-
fore, predicts possible transient differences in multi-
site protein signal transduction in response to fast
transient kinetics of multisite proteins.
Fig. 8 The comparison between the cases where the free ligand concentration is barely affected by interaction and exhausted as a result of
buffering. The kinetics of multisite protein species alterations in response to step change in ligand concentration from UT0/K = 0.01 to UT1/K = 200
for two different ratios of the protein concentration to the affinities of the binding sites LT/K = 2 a for the intermediate species N1/LT, N2/LT and
N3/LT, b for the apo- and fully bound species N0/LT and N4/LT respectively) and LT/K = 50 c for the intermediate species N1/LT, N2/LT and N3/LT, d for
the apo- and fully bound species N0/LT and N4/LT respectively). The model predicts that due to the lack of available ligand and buffering by the
multisite protein in the case of limited amount of ligand, the multisite protein is unable to become fully saturated after the step change in
ligand, and the majority of the ligand becomes distributed among the intermediate species. e. The comparison of the dynamics of free ligand
concentration U/K after step change in ligand. The amount of available ligand is barely altered for LT/K = 2, and exhausted when the ratio of total
protein concentration to the binding constant is LT/K = 50
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Discussion
In this paper we analysed multisite protein kinetics in
response to rapid changes in ligand concentrations. The
model for multisite protein kinetics for variable number
of bound ligands was developed for two physiological
cases: when the concentration of ligand is much higher
[55, 56] and when it is comparable with the concentra-
tion of the multisite protein [57]. The results obtained
by the proposed model allow for an accurate interpret-
ation of the experimental data for the concentration of
multisite proteins such as CaM, TnC, CaN and other
Ca2+ dependent secondary messengers regulated by Ca2+
ions. The kinetic effects in response to ligand binding
[13, 58, 59], required for understanding of pathway regu-
lation, can be interpreted by the presented model.
The approach developed in this project is applicable to
a number of areas of kinetic experiments. One of them
is widely used techniques to study chemical kinetics
using the pressure jump technique [12, 60, 61]. Accord-
ing to our model, the effects induced by rapid change in
pressure leading to the change in protein-ligand interac-
tions [12, 60, 61], can be interpreted and explained by
the alteration in the affinities of the binding constants of
multisite proteins. The time dynamics of the individual
multisite protein species can offer new insights into the
underlying biophysical mechanism of ligand-protein in-
teractions in response to fast change.
Our model shows that the concentration of intermedi-
ate conformations as a function of time represents
skewed bell shapes. We found that as the protein con-
centration rises, free ligand concentration becomes
exhausted [13]. This result is consistent with experimen-
tally observed Ca2+-CaM-dependent inhibition of my-
osin motor function [62]. The results obtained by this
model increase our understanding of differential activa-
tion of protein phosphatase 2B (PP2B) [59, 63] and cal-
cium/calmodulin-dependent protein kinase II (CaMKII)
[64, 65] kinetics. PP2B binding increases the affinity of
CaM for its targets [59] and, therefore, is likely be acti-
vated by low amounts of calcium.
The presented model offers a new tool for the interpret-
ation of transient kinetics experiments performed by the
flash photolysis and stopped-flow techniques [66–68].
Availability of a caged analogue of the necessary reactant
is considered as one of the biggest problems of flash pho-
tolysis [66], which can be overcome by employing the pro-
posed model with the low amount of protein. A less
obvious area of application for this methodology is the
kinetics of proteins with multiple phosphorylation sites
[69–72]. This work shows that the highly versatile intra-
cellular multifunctionality of multisite proteins is achieved
not only by the order of ligand-protein interaction and the
number of bound ligands, but also by temporal regulation.
Conclusions
The developed in this study models for the kinetics of
the multisite ligand-receptor binding for the two physio-
logical cases, where the ligand concentration is abundant
and comparable with the protein concentration, make
universal predictions for the temporal distribution of
multisite protein conformations in complex with variable
numbers of ligands. The strongest effect of the ligand
availability is observed for the multisite protein confor-
mations with larger numbers of bound ligands. The two
models show that the concentration of individual multi-
site protein conformations changes with time nonli-
nearly and that the temporal distribution for the
concentrations of the intermediate conformations repre-
sents skewed bell shapes. The models derive the charac-
teristic times and the dynamics for the kinetic responses
elicited by a ligand concentration change as a function
of ligand concentration and the number of ligand bind-
ing sites. The developed models allow for a novel and ac-
curate interpretation of concentration and pressure jump-
dependent kinetic experiments. Our models are applied to
study the kinetics of calmodulin, however the models also
provide universal predictions and allow us to extend the
understanding of a large number of multisite binding-
regulated circuits and the mechanisms underlying dy-
namic ligand-dependent regulation of multisite proteins.
Fig. 9 Model predictions for the time required for multisite protein conformations to reach their maximal and half growth concentrations. The
non-dimensional characteristic times, τmmaxk− (m = 1, 2, 3) for intermediate (a), τ00.5k− for apo- and τ40.5k− for fully bound (b) multisite protein
conformations are shown as a function of the step change ligand concentration from UT0/K = 0.1 to UT1/K and LT/K = 3
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Methods
Kinetic properties of multisite proteins with n binding
sites
Here, we describe mathematical equations used to de-
scribe dynamic interactions of ligand molecules with
multisite proteins. The model described in this section
extends our previous analysis for multisite protein inter-
actions under steady-state conditions [22–24].
Multisite protein with independent ligand binding sites
The kinetic scheme for such interaction can be repre-
sented as follows:
L0i þ U⇄
kþi
k−i
L1i ; i ¼ 0;…; n−1; ð1Þ
where Li
0 is the ith binding site of the multisite protein
in unbound state, U is a ligand molecule, Li
1 is the ith
binding site of the multisite protein being occupied,
ki
+ and ki
− are the association and dissociation rates
respectively.
The probabilities for the ith binding site to be not
occupied or occupied as a function of ligand concentra-
tion U are given by:
p0i Uð Þ ¼
Ki
Ki þ U ;
p1i Uð Þ ¼
U
Ki þ U ;
ð2Þ
where Ki ¼ k
−
i
kþi
:
There are two possible states of a binding site: occu-
pied or not occupied. Since the number of sites in the
molecule is n, there are 2n possible molecular forms, i.e.
the states characterized by combinations of bound and
free sites.
The probability for a multisite protein with independ-
ent binding sites to be in a particular molecular form is
given by multiplications of probabilities of ligand bind-
ing at each site:
Pj Uð Þ ¼
Yn−1
i¼0
pci jð Þi Uð Þ; j ¼ 0;…; 2n−1; ð3Þ
where j ¼
Xn−1
i¼0
2ici jð Þ is the number of possible molecular
form, ci(j) = 0 or ci(j) = 1 for free or occupied binding
site, respectively.
The kinetics of multisite protein interactions with
abundant ligand concentrations (UT > > LT)
In this case we assume the ligand concentration only
changes at a given time point (t = 0) in a step fashion
from U0 to U1 and remains constant otherwise.
The probability of a multisite protein being occupied
by ligand molecules as it was shown in Eq. (3) as a func-
tion of time can be reformulated as follows:
Pj U ; tð Þ ¼
Yn−1
i¼0
pci jð Þi U ; tð Þ; j ¼ 0;…; 2n−1: ð4Þ
pci jð Þi U ; tð Þ can be determined by considering the ori-
ginal set of ordinary differential equations for single site
interaction of a protein with a ligand according to Eq.
(1) [24]:
dL0i U ; tð Þ
dt
¼ −kþi ⋅L0i U ; tð Þ⋅U1 þ k−i ⋅L1i U ; tð Þ;
dL1i U ; tð Þ
dt
¼ kþi ⋅L0i U ; tð Þ⋅U1−k−i ⋅L1i U ; tð Þ;
L0i U ; tð Þ þ L1i U ; tð Þ ¼ LT ;
ð5Þ
where Li
0(U, t) is the concentration of a free binding site,
Li
1(U, t) is the concentration of a bound ligand molecule
and LT is the total number of the protein molecules.
Here we use steady-state solutions L0i Uð Þ ¼ LT KiKiþU
and L1i Uð Þ ¼ LT UKiþU as initial conditions for the ligand
concentration jump from U0 to U1. A particular solution
for the system of differential Eqs. (5) in response to the
ligand concentration shift from U0 to U1 is given by:
L0i U ; tð Þ ¼ LT ⋅
Ki
Ki þU1 −
Ki
Ki þ U1 −
Ki
Ki þ U0
 
⋅ exp −
t
τ U1ð Þ
  
;
L1i U ; tð Þ ¼ LT ⋅
U1
Ki þU1 −
U1
Ki þ U1 −
U0
Ki þ U0
 
⋅ exp −
t
τ U1ð Þ
  
;
ð6Þ
where τ U1ð Þ ¼ Kik−i ⋅ U1þKið Þ ;Ki ¼
k−i
kþi
:
The normalisation of the solution (6) by the total pro-
tein concentration allows the definition of probability of
the ith binding site to be in an occupied pi
1(U, t) or un-
occupied pi
0(U, t) state, respectively, at a given ligand
concentration:
p0i U ; tð Þ ¼ p0i U1ð Þ− p0i U1ð Þ−p0i U0ð Þ
 
⋅ exp −
t
τ U1ð Þ
 
;
p1i U ; tð Þ ¼ p1i U1ð Þ− p1i U1ð Þ−p1i U0ð Þ
 
⋅ exp −
t
τ U1ð Þ
 
:
ð7Þ
At any given time the total concentration of the pro-
tein, LT, is conserved and the sum of the probabilities (7)
equals 1:
L0i U ; tð Þ þ L1i U ; tð Þ ¼ LT ;
p0i U ; tð Þ þ p1i U ; tð Þ ¼ 1
ð8Þ
In the most general case, the concentration of the
jth molecular form, Mj(U, t), of a molecule with n differ-
ent binding sites in response to a step in ligand
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concentration is given by the product of probabilities (7)
according to Eq. (4):
Mj U ; tð Þ ¼ LT ⋅
Yn−1
i¼0
pсi jð Þi U ; tð Þ; j ¼ 0;…; 2n−1; ð9Þ
where ci(j) = 0 or ci(j) = 1 for free or occupied ith binding
site respectively.
The probabilities for individual molecular forms in
steady-state can be obtained from Eq. (9) by setting
t→∞:
Mj Uð Þ ¼ LT ⋅
Yn−1
i¼0
pci jð Þi Uð Þ; j ¼ 0;…; 2n−1; ð10Þ
The kinetics of the amount of ligand bound to a multi-
site protein with n binding sites can be written as
follows:
S U ; tð Þ ¼
X2n−1
j¼0
Mj U ; tð Þ
Xn−1
i¼0
ci jð Þ: ð11Þ
Multisite proteins with identical ligand binding sites
The multisite proteins that contain n identical binding
sites with equilibrium dissociation constant equal K
¼ k−
kþ can then be considered. The steady-state con-
centration of one of the molecular forms of multisite
protein with n identical binding sites for m bound
sites, as a function of ligand concentration [22, 24] is
given by:
Nm Uð Þ ¼ LT ⋅U
m⋅Kn−m
K þUð Þn ; m ¼ 0; 1;…; n: ð12Þ
For intermediate forms the N1(U),…,Nn − 1(U) species
dependence on ligand concentration represents a bell
shape with one molecular form “magnitude” at a par-
ticular ligand concentration Um
max.
Differentiating Eq. (12) with respect to U and solving
dN/dU = 0 for U gives:
Umaxm ¼
K ⋅m
n−m
; m ¼ 1; 2;…; n−1: ð13Þ
The magnitudes Nm
max of the intermediate conforma-
tions Nm corresponding to Um
max values are:
Nmaxm ¼ LT ⋅
mm
nn
n−mð Þn−m; m ¼ 1; 2;…; n−1: ð14Þ
The multisite protein conformations in the apo-,
N0, and in the fully saturated states, Nn, would
reach their maximum that equal to the total multi-
site protein concentration LT under conditions of
very low and very high ligand concentrations,
respectively.
Equation (12) can be used to estimate the half
maximal effective ligand concentration (EC50), U0
0.5
and Un
0.5, for the apo- and saturated multisite
protein conformations respectively, when the pro-
tein species equal 50 % of the total concentration
LT:
U0:50 ¼ K ⋅
1−
ﬃﬃﬃﬃﬃﬃ
0:5n
pﬃﬃﬃﬃﬃﬃ
0:5n
p ;
U0:5n ¼ K ⋅
ﬃﬃﬃﬃﬃﬃ
0:5n
p
1−
ﬃﬃﬃﬃﬃﬃ
0:5n
p ≈K ⋅ 1:44⋅n−0:44ð Þ:
ð15Þ
It can be noted that the half maximal effective ligand
concentration is equal to equilibrium dissociation con-
stant (EC50 = K) in proteins with only one binding site
(n = 1).
Equations (15) can be solved with respect to n:
n ¼ 0:693⋅ ln K þ U
0:5
n
U0:5n
  −1
ð16Þ
Equation (11) can be used to derive the full amount of
ligand bound to multisite protein for U = K:
S K ; tð Þ ¼ 1
4
⋅S Usat; tð Þ; ð17Þ
where Usat is the ligand concentration for the case when
all binding sites are occupied. The amount of bound
ligand for U =Usat is given by S(Usat, t) = n ⋅ LT and for
U = K is given by
S K ; tð Þ ¼ LT
2n
⋅
1
2
⋅n⋅2n−1: ð18Þ
The dynamic alterations of intermediate conformation
Nm(U, t) in response to ligand concentration jump from
U0 to U1 according to Eqs. (6) and (7) are given by:
Nm U ; tð Þ ¼ LT ⋅ p1 U ; tð Þð Þm⋅ p0 U ; tð Þð Þn−m;
p0 U ; tð Þ ¼ K
K þ U1 −
K
K þU1 −
K
K þ U0
0
@
1
A⋅ exp − t
τ U1ð Þ
0
@
1
A;
p1 U ; tð Þ ¼ U1
K þ U1 −
U1
K þU1 −
U0
K þ U0
0
@
1
A⋅ exp − t
τ U1ð Þ
0
@
1
A;
τ U1ð Þ ¼ Kk−⋅ U1 þ Kð Þ :
ð19Þ
Differentiating Eq. (19) with respect to t and solving
for dNm/dt = 0 yields the time τm
max when the multisite
protein forms Nm with m bound molecules of ligand
reach their maximal values Nm
max:
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τmaxm ¼ τ U1ð Þ⋅ ln
n⋅K ⋅ U1−U0ð Þ
K þ U0ð Þ⋅ n−mð Þ⋅U1−m⋅Kð Þ
 
;
m ¼ 1; 2;…; n−1:
ð20Þ
The substitution of τm
max into Eq. (19) gives the max-
imal values of intermediate multisite protein conforma-
tions reached at τm
max:
Nmaxm ¼ LT ⋅
mm
nn
n−mð Þn−m; m ¼ 1; 2;…; n−1: ð21Þ
Comparison of Eqs. (14) and (21) suggests that
the steady-state maximum values of intermediate
multisite protein conformations steady-state are
similar to those transiently reached during the dy-
namic response to the step in ligand concentration.
According to Eq. (19) Nm(U, t) for the apo- and fully
saturated forms when t = 0:
N0 U ; 0ð Þ ¼ LT ⋅ KK þ U0
 n
;
Nn U ; 0ð Þ ¼ LT ⋅ U0K þU0
 n
:
ð22Þ
According to Eq. (12) steady state levels for the apo-
and fully saturated forms when t→∞:
N0 U ;∞ð Þ ¼ LT ⋅ KK þ U1
 n
;
Nn U ;∞ð Þ ¼ LT ⋅ U1K þ U1
 n
:
ð23Þ
Equation (19) is further used to define the time,
τ0
0.5, required for the apo- form, N0, to reach half of
the growth concentration N0 U;∞ð ÞþN0 U ;0ð Þ2 and the time
period, τn
0.5, required for the fully saturated protein
species to gain half of the growth concentration
Nn U;∞ð ÞþNn U ;0ð Þ
2 (Fig. 3):
Multisite proteins with four identical ligand binding sites
This study next considered the kinetic properties of a
protein with 4 binding sites. This allows 24 = 16 molecu-
lar forms, each with potentially unique biochemical
properties. There are 4 possible combinations of protein
species bound to one or to three ligands, and 6 possible
distinct molecular forms with two sites occupied. In the
previous work we described the steady-state dependence
of the individual multisite conformations on lig-
and concentration [22–24]. Here we analyse the
kinetic transition of the individual species con-
centrations in response to the step in ligand
concentration.
The dynamical alterations of intermediate conform-
ation Nm(U, t) in response to a step in ligand concentra-
tion from U0 to U1 according to Eq. (19) are given by:
Nm u; ηð Þ ¼ LT ⋅ p1 u; ηð Þð Þm⋅ p0 u; ηð Þð Þ4−m;
p0 u; ηð Þ ¼ 1
1þ u1 −
1
1þ u1 −
1
1þ u0
 
⋅ exp −η⋅ u1 þ 1ð Þð Þ;
p1 u; ηð Þ ¼ u1
1þ u1 −
u1
1þ u1 −
u0
1þ u0
 
⋅ exp −η⋅ u1 þ 1ð Þð Þ;
ð25Þ
where: u0 ¼ U0K , u1 ¼ U1K are non-dimensional ligand
concentrations, and η = t ⋅ k− is non-dimensional time.
k− and K ¼ k−
kþ are the dissociation and equilibrium
dissociation constants for ligand binding, respectively.
The maximum values of Nm
max are reached at
the following ligand concentrations: umax1 ¼ K3 ,
u2
max = K, u3
max = 3K, for the multisite protein spe-
cies with one, two and three bound ions, respect-
ively according to Eq. (13) and equal N1
max =
0.105LT, N2
max = 0.063LT, N3
max = 0.105LT, according
to Eq. (14).
Differentiating Eq. (25) with respect to η and solv-
ing dNm/dη = 0 for η gives the non-dimensional time
τ0:50 ¼ τ U1ð Þ⋅ ln K ⋅
U1−U0
K þ U0ð Þ⋅ K þ U1ð Þ⋅ 0:5⋅ KK þ U0
 n
þ K
K þ U1
 n  1
n−K
0
B@
1
CA
0
BBBBBBBBB@
1
CCCCCCCCCA
;
τ0:5n ¼ τ U1ð Þ⋅ ln K ⋅
U1−U0
K þ U0ð Þ⋅ U1− K þ U1ð Þ⋅ 0:5⋅ U0K þ U0
 n
þ U1
K þU1
 n  1
n
0
B@
1
CA
0
BBBBBBBBB@
1
CCCCCCCCCA
:
ð24Þ
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ηm
max = τm
maxk− when the intermediate species reach
their maximum:
ηmax1 ¼ τmax1 k− ¼
1
u1 þ 1 ln
4⋅ u1−u0ð Þ
1þ u0ð Þ⋅ 3u1−1ð Þ
 
;
ηmax2 ¼ τmax2 k− ¼
1
u1 þ 1 ln
2⋅ u1−u0ð Þ
1þ u0ð Þ⋅ u1−1ð Þ
 
;
ηmax3 ¼ τmax3 k− ¼
1
u1 þ 1 ln
4⋅ u1−u0ð Þ
1þ u0ð Þ⋅ u1−3ð Þ
 
:
ð26Þ
Equations (26) suggest that η1
max, η2
max and η3
max are
undefined when u1 < 13 ; u1 < 1 and u1 < 3; respectively
(q1, q2 and q3 asymptotes). Under these conditions, the
intermediate species do not reach the maximum in re-
sponse to ligand step, instead their relative number in-
crease in a monotonous manner.
Multisite proteins with four different ligand binding sites
In this section we analyse the kinetic properties of a
multisite protein with four different binding sites. The
steady-state analysis can be found in the authors previ-
ous investigation [22, 24].
It is assumed that all association k1
+, k2
+, k3
+, k4
+ and dis-
sociation k1
−, k2
−, k3
−, k4
− rates are unique for each binding
centre. Then assuming for example that k1
+ > k2
+ > k3
+ > k4
+
and k1
− = k2
− = k3
− = k4
−. The non-dimensional concen-
tration u ¼ UK and non-dimensional constants h1 = 1,
h2 ¼ k
þ
2
kþ1
, h3 ¼ k
þ
3
kþ1
, h4 ¼ k
þ
4
kþ1
, h1
− = 1, h−2 ¼ k
−
2
k−1
¼ 1, h−3 ¼ k
−
3
k−1
¼ 1, h−4 ¼ k
−
4
k−1
¼ 1 can be introduced..
The set of Eqs. (25) can then be employed to calculate
the dynamics of the multisite protein conformations
bound to a different number of ligand molecules.
Multisite proteins with two pairs of cooperative binding
sites
The molecule contains two independent domains A and
B, with two identical cooperative binding sites. The
domain A is described as follows:
A00 þ U⇄
kþ1
k−1
A10
A00 þ U⇄
kþ1
k−1
A01
A10 þ U⇄
kсþ1
kс−1
A11
A01 þ U⇄
kсþ1
kс−1
A11
ð27Þ
The ODEs for the scheme (27) is given by:
dA00 U ; tð Þ
dt
¼ −2kþ1 ⋅A00 U ; tð Þ⋅U þ k−1 ⋅A10 U ; tð Þ
þk−1 ⋅A01 U ; tð Þ;
dA10 U ; tð Þ
dt
¼ kþ1 ⋅A00 U ; tð Þ⋅U−k−1 ⋅A10 U ; tð Þ−kcþ1
A10 U ; tð Þ⋅U þ kc−1 ⋅A11 U ; tð Þ;
dA01 U ; tð Þ
dt
¼ kþ1 ⋅A00 U ; tð Þ⋅U−k−1 ⋅A01 U ; tð Þ−kcþ1
A01 U ; tð Þ⋅U þ kc−1 ⋅A11 U ; tð Þ;
dA11 U ; tð Þ
dt
¼ kcþ1 ⋅A01 U ; tð Þ⋅U þ kcþ1 ⋅A10 U ; tð Þ
U−2kc−1 ⋅A11 U ; tð Þ;
ð28Þ
The total number of species that follows from Eqs.
(28) is given by:
A00 U ; tð Þ þ A10 U ; tð Þ þ A01 U ; tð Þ þ A11 U ; tð Þ ¼ AT :
ð29Þ
The steady-state solutions of the system (28) are given
by:
A00 Uð Þ ¼ AT ⋅ K 1⋅K
c
1
U2 þ 2⋅Kc1⋅U þ K1⋅Kc1
;
A10 Uð Þ ¼ AT ⋅ U⋅K
c
1
U2 þ 2⋅Kc1⋅U þ K1⋅Kc1
;
A01 Uð Þ ¼ AT ⋅ U⋅K
c
1
U2 þ 2⋅Kc1⋅U þ K1⋅Kc1
;
A11 Uð Þ ¼ AT ⋅ U
2
U2 þ 2⋅Kc1⋅U þ K1⋅Kc1
;
ð30Þ
where K1 ¼ k
−
1
kþ1
and Kc1 ¼ kc
−
1
kcþ1
.
One can re-write Eqs. (30) as follows:
a0 Uð Þ ¼ K1⋅K
c
1
U2 þ 2⋅Kc1⋅U þ K1⋅Kc1
;
a1 Uð Þ ¼ U⋅K
c
1
U2 þ 2⋅Kc1⋅U þ K1⋅Kc1
;
a2 Uð Þ ¼ U
2
U2 þ 2⋅Kc1⋅U þ K1⋅Kc1
;
ð31Þ
where a0 Uð Þ ¼ A00 Uð ÞAT ; a1 Uð Þ ¼
A10 Uð Þ
AT
¼ A01 Uð ÞAT ; a2 Uð Þ ¼
A11 Uð Þ
AT
are the probabilities for the domain to be in a
particular conformation due to the bound ligand
molecules.
The probabilities for the other domain, which also
contains a pair of cooperative binding sites, are given by:
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b0 Uð Þ ¼ K 2⋅K
c
2
U2 þ 2⋅Kc2⋅U þ K2⋅Kc2
;
b1 Uð Þ ¼ U⋅K
c
2
U2 þ 2⋅Kc2⋅U þ K2⋅Kc2
;
b2 Uð Þ ¼ U
2
U2 þ 2⋅Kc2⋅U þ K2⋅Kc2
;
ð32Þ
These probabilities were derived for the two domains
of molecule (Eqs. (31) and (32) respectively). The prob-
abilities of the molecule to be in a certain conformation
with 0, 1 or 2 bound ligands in each of the domains, are
as follows:
p0;0 Uð Þ ¼ a0 Uð Þ⋅b0 Uð Þ;
p0;1 Uð Þ ¼ a0 Uð Þ⋅2b1 Uð Þ;
p0;2 Uð Þ ¼ a0 Uð Þ⋅b2 Uð Þ;
p1;0 Uð Þ ¼ 2a1 Uð Þ⋅b0 Uð Þ;
p1;1 Uð Þ ¼ 2a1 Uð Þ⋅2b1 Uð Þ;
p1;2 Uð Þ ¼ 2a1 Uð Þ⋅b2 Uð Þ;
p2;0 Uð Þ ¼ a2 Uð Þ⋅b0 Uð Þ;
p2;1 Uð Þ ¼ a2 Uð Þ⋅2b1 Uð Þ;
p2;2 Uð Þ ¼ a2 Uð Þ⋅b2 Uð Þ;
ð33Þ
where pi,j(U) is the probability of the protein conform-
ation with i bound sites in the first domain and j bound
sites in the other. We use the sum of probabilities for
the case of 1 bound site in a domain since we assume
that all the sites in each domain are identical.
The concentrations of the molecular forms of the pro-
tein with certain number of bound sites are given by:
N0 Uð Þ ¼ LT ⋅p0;0 Uð Þ;
N1 Uð Þ ¼ LT ⋅ p0;1 Uð Þ þ p1;0 Uð Þ
 
;
N2 Uð Þ ¼ LT ⋅ p0;2 Uð Þ þ p1;1 Uð Þ þ p2;0 Uð Þ
 
;
N3 Uð Þ ¼ LT ⋅ p1;2 Uð Þ þ p2;1 Uð Þ
 
;
N4 Uð Þ ¼ LT ⋅p2;2 Uð Þ;
ð34Þ
One can rewrite Eq. (34) as follows:
N0 Uð Þ
LT
¼ a0 Uð Þ⋅b0 Uð Þ;
N1 Uð Þ
LT
¼ 2⋅ a0 Uð Þ⋅b1 Uð Þ þ a1 Uð Þ⋅b0 Uð Þð Þ;
N2 Uð Þ
LT
¼ a0 Uð Þ⋅b2 Uð Þ þ 4⋅a1 Uð Þ⋅b1 Uð Þ þ a2 Uð Þ⋅b0 Uð Þ;
N3 Uð Þ
LT
¼ 2⋅ a1 Uð Þ⋅b2 Uð Þ þ a2 Uð Þ⋅b1 Uð Þð Þ;
N4 Uð Þ
LT
¼ a2 Uð Þ⋅b2 Uð Þ;
ð35Þ
Next we find the kinetic solution of system (28) for
U =U1:
dA00 U ; tð Þ
dt
¼ −2kþ1 ⋅A00 U ; tð Þ⋅U1 þ k−1 ⋅A10 U ; tð Þ
þk−1 ⋅A01 U ; tð Þ;
dA10 U ; tð Þ
dt
¼ kþ1 ⋅A00 U ; tð Þ⋅U1−k−1 ⋅A10 U ; tð Þ−kcþ1
A10 U ; tð Þ⋅U1 þ kc−1 ⋅A11 U ; tð Þ;
dA01 U ; tð Þ
dt
¼ kþ1 ⋅A00 U ; tð Þ⋅U1−k−1 ⋅A01 U ; tð Þ−kcþ1
A01 U ; tð Þ⋅U1 þ kc−1 ⋅A11 U ; tð Þ;
dA11 U ; tð Þ
dt
¼ kcþ1 ⋅A01 U ; tð Þ⋅U1þkcþ1 ⋅A10 U ; tð Þ
U1−2kc−1 ⋅A11 U ; tð Þ;
ð36Þ
The kinetics of multisite protein interactions with
constant ligand concentrations
In this section we consider the mechanism of multisite
binding for the case when the total ligand concentration
is conserved. Under this assumption the system of differ-
ential equations for ligand binding to a molecule with
single binding site (5) needs to be complemented by the
law of ligand conservation:
dL0 U ; tð Þ
dt
¼ −kþ⋅L0 U ; tð Þ⋅U tð Þ þ k−⋅L1 U ; tð Þ;
dL1 U ; tð Þ
dt
¼ kþ⋅L0 U ; tð Þ⋅U tð Þ−k−⋅L1 U ; tð Þ;
L0 U ; tð Þ þ L1 U ; tð Þ ¼ LT ;
U tð Þ þ L1 U ; tð Þ ¼ UT ;
ð37Þ
where L0 is the concentration of the free site, L1 is the
concentration of the occupied site, UT and LT are the
total concentrations of ligand and protein molecules,
respectively.
There is only one positive steady-state solution of the
system (37):
L0 UTð Þ ¼ K2 ⋅
LT
K
−
UT
K
−1þ F UTð Þ
 
;
L1 UTð Þ ¼ K2 ⋅
LT
K
þ UT
K
þ 1−F UTð Þ
 
;
U ¼ UT−K2 ⋅
LT
K
þ UT
K
þ 1−F UTð Þ
 
;
ð38Þ
where K ¼ k−
kþ and F UTð Þ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
UT
K −
LT
K
 2 þ 2⋅ UTK þ LTK þ 1
q
:
We use the steady-state solutions (38) as initial condi-
tions to find the particular solution. The solution of the
system (37) in response to the ligand concentration
jump from UT0 to UT1 is given by:
Salakhieva et al. BMC Systems Biology  (2016) 10:32 Page 15 of 19
L0 UT ; tð Þ ¼ LT ⋅

K
2⋅LT
⋅

LT
K
−
UT1
K
−1þ F UT1ð Þ
C UTð Þ⋅ exp t⋅k
−⋅F UT1ð Þð Þ þ 1
C UTð Þ⋅ exp t⋅k−⋅F UT1ð Þð Þ−1

;
L1 UT ; tð Þ ¼ LT ⋅

1−
K
2⋅LT
⋅

LT
K
−
UT1
K
−1þ F UT1ð Þ
C UTð Þ⋅ exp t⋅k
−⋅F UT1ð Þð Þ þ 1
C UTð Þ⋅ exp t⋅k−⋅F UT1ð Þð Þ−1

;
U tð Þ ¼ UT1−LT ⋅

1−
K
2⋅LT
⋅

LT
K
−
UT1
K
−1þ F UT1ð Þ
C UTð Þ⋅ exp t⋅k
−⋅F UT1ð Þð Þ þ 1
C UTð Þ⋅ exp t⋅k−⋅F UT1ð Þð Þ−1

:
ð39Þ
where C UTð Þ ¼ F UT0ð ÞþF UT1ð Þþ
UT1
K −
UT0
K
F UT0ð Þ−F UT1ð ÞþUT1K −
UT0
K
:
The normalisation of the solution (39) by the total
protein concentration allows the definition of probability
of the binding site to be in an occupied p1(UT, t) or un-
occupied p0(UT, t) state, respectively, at a given total lig-
and concentration:
p0 UT ; ηð Þ ¼ K2⋅LT ⋅
 
LT
K
−
UT1
K
−1þ F UT1ð Þ
 C2 UTð Þ⋅ exp η⋅F UT1ð Þð Þ þ 1
C2 UTð Þ⋅ exp η⋅F UT1ð Þð Þ−1
!
;
p1 UT ; ηð Þ ¼ K2⋅LT ⋅
 
LT
K
þ UT1
K
þ 1−F UT1ð Þ
 C2 UTð Þ⋅ exp η⋅F UT1ð Þð Þ þ 1
C2 UTð Þ⋅ exp η⋅F UT1ð Þð Þ−1
!
;
U ηð Þ
K
¼ UT1
K
−
1
2
⋅
 
LT
K
þ UT1
K
þ 1−F UT1ð Þ
 C2 UTð Þ⋅ exp η⋅F UT1ð Þð Þ þ 1
C2 UTð Þ⋅ exp η⋅F UT1ð Þð Þ−1
!
;
ð40Þ
where η = t ⋅ k−.
The concentration of the jth molecular form,
Mj(UT, t), of a protein with n independent binding
sites in response to a step change in ligand concen-
tration is given by the product of probabilities accord-
ing to Eq. (9):
Mj UT ; tð Þ ¼ LT ⋅
Yn−1
i¼0
pсi jð Þ UT ; tð Þ; j ¼ 0;…; 2n−1
ð41Þ
where ci(j) equals 0 or 1 for free and occupied sites,
respectively and j ¼
Xn−1
i¼0
2ici jð Þ.
The kinetics of the amount of ligand bound to a multi-
site protein with n independent binding sites can be
written as follows:
S UT ; tð Þ ¼
X2n−1
j¼0
Mj UT ; tð Þ
Xn−1
i¼0
ci jð Þ: ð42Þ
The concentration of free ligand can be written
as the difference between the total ligand con-
centration and the bound ligand concentration
(42):
U tð Þ ¼ UT1−S UT ; tð Þ; ð43Þ
The probabilities of the ith site to be free or occupied
respectively for the molecule with n independent bind-
ing sites in this case:
p0i UT ; ηð Þ ¼
Ki
2⋅n⋅LT
⋅
 
n⋅LT
Ki
−
UT1
Ki
−1þ F UT1ð Þ
 C UTð Þ⋅ exp η⋅F UT1ð Þð Þ þ 1
C UTð Þ⋅ exp η⋅F UT1ð Þð Þ−1
!
;
p1i UT ; ηð Þ ¼
Ki
2⋅n⋅LT
⋅
 
n⋅LT
Ki
þ UT1
Ki
þ 1−F UT1ð Þ
 C UTð Þ⋅ exp η⋅F UT1ð Þð Þ þ 1
C UTð Þ⋅ exp η⋅F UT1ð Þð Þ−1
!
;
ð44Þ
where F UTð Þ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
UT
Ki
− n⋅LTKi
 2
þ 2⋅ UTKi þ n⋅LTKi
 
þ 1
r
and
C UTð Þ ¼ F UT0ð ÞþF UT1ð Þþ
UT1
Ki
−UT0Ki
F UT0ð Þ−F UT1ð ÞþUT1Ki −
UT0
Ki
:
The dynamic alterations of the molecular
forms with m bound out of n independent
identical binding sites Nm(UT, t) in response to
the total ligand concentration jump from UT0
to UT1 according to Eqs. (19) and (44) are
given by:
Nm UT ; tð Þ ¼ LT ⋅ p1 UT ; tð Þ
 m
⋅ p0 UT ; tð Þ
 n−m
: ð45Þ
The concentration of multisite protein conformations,
Nm, bound to m ligand molecules as a function of ligand
concentration in steady-state is given by:
Nm UTð Þ ¼ LT K2nLT
nLT
K
þUT
K
þ 1−F UTð Þ
  m
 K
2nLT
nLT
K
−
UT
K
−1þ F UTð Þ
  n−m
ð46Þ
The ligand concentrations, Um
max, for the maximal
values of intermediate protein conformations, Nm(Um
max),
can be found by differentiating Eq. (46) with respect to
UT and solving dNm/dUT = 0 for UT:
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Umaxm ¼ m⋅ LT þ
K
n−m
 
ð47Þ
The corresponding maximal magnitudes for the inter-
mediate conformations are given by:
Nm U
max
m
  ¼ LT ⋅mmnn ⋅ n−mð Þn−m ð48Þ
The half maximal effective ligand concentration, U0
0.5
and Un
0.5, when the protein species equal half of the total
concentration LT, for the apo- and saturated multisite
protein conformations respectively, in this case are given
by:
U0:50 ¼

1−
ﬃﬃﬃﬃﬃﬃ
0:5n
p Þ⋅
 
n⋅LT þ K
ﬃﬃﬃﬃﬃﬃ
0:5
n
q !
;
U0:5n ¼
ﬃﬃﬃﬃﬃﬃ
0:5n
p
⋅
 
n⋅LT þ K
1−
ﬃﬃﬃﬃﬃﬃ
0:5n
p
!
:
ð49Þ
Differentiating Eq. (45) with respect to t and
solving for dNm/dt = 0 yields the time τm
max when
the concentration of multisite protein conforma-
tions, Nm, bound to m ligand molecules is
maximal:
τmaxm ¼ H V mð Þð Þ; ð50Þ
where H xð Þ ¼
ln
1þUT1K þF UT1ð Þþx
C UTð Þ⋅ 1þUT1K −F UT1ð Þþxð Þ
 
F UT1ð Þ⋅k− and V mð Þ ¼
LT
K ⋅ n−2mð Þ:
Equation (50) has an asymptote UT1K for 1þ UT1K −F
UT1ð Þ þ x ¼ 0:
qm ¼ m⋅
LT
K
þ 1
n−m
 
; ð51Þ
Equation (45) is further used to define the
time, τ0
0.5, required for the apo- form, N0, to
reach half of the growth concentration and the
time period, τn
0.5, required for the fully saturated
protein species to gain half of the growth
concentration:
τ0:50 ¼ H Wð Þ;
τ0:5n ¼ H Yð Þ;
ð52Þ
where
W ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
−
UT1
K
þ LT
K
⋅nþ F UT1ð Þ−1
 n
þ −UT0
K
þ LT
K
⋅nþ F UT0ð Þ−1
 n
2
n
vuuut
−
LT
K
⋅n;
Y ¼ LT
K
⋅n−
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
UT1
K
þ LT
K
⋅n−F UT1ð Þ þ 1
 n
þ UT0
K
þ LT
K
⋅n−F UT0ð Þ þ 1
 n
2
n
vuuut
:
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